Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Almost 600K shares traded US side

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Jan 23, 2023 3:32pm

154 Views

Post# 35240537

RE:Almost 600K shares traded US side

N0taP00p wrote: Either someone knows something about an impending cash raise or FDA delay, or it is related to warrants like some people are assuming. It is sheer nonsense to assume that someone posting on a stock board is moving the stock. I'm sure we'll know soon enough.

I think someone is taking advantage of running stops. Should be an interesting close and week.

:-)

<< Previous

Bullboard Posts

Next >>

Fobi AI responds to cease trade order, filing delay “disappointing”